The Discounted Cash Flow (DCF) valuation of Dr Sulaiman Al-Habib Medical Services Group Co (4013.SR) is 155.02 SAR. With the latest stock price at 254.80 SAR, the upside of Dr Sulaiman Al-Habib Medical Services Group Co based on DCF is -39.2%.
Based on the latest price of 254.80 SAR and our DCF valuation, Dr Sulaiman Al-Habib Medical Services Group Co (4013.SR) is a sell. selling 4013.SR stocks now will result in a potential gain of 39.2%.
| Range | Selected | |
| WACC / Discount Rate | 10.9% - 13.4% | 12.2% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 122.09 - 210.87 | 155.02 |
| Upside | -52.1% - -17.2% | -39.2% |